(19)
(11) EP 1 100 532 A2

(12)

(88) Date of publication A3:
03.08.2000

(43) Date of publication:
23.05.2001 Bulletin 2001/21

(21) Application number: 99937658.5

(22) Date of filing: 29.07.1999
(51) International Patent Classification (IPC)7A61K 38/31, A61P 1/04, A61P 1/12, A61P 1/14, A61P 1/18, A61P 3/08, A61P 5/02, A61P 5/08, A61P 5/18, A61P 5/48, A61P 9/02, A61P 9/10, A61P 9/12, A61P 17/02, A61P 17/06, A61P 19/08, A61P 25/18, A61P 35/00, A61P 43/00
(86) International application number:
PCT/US9917/294
(87) International publication number:
WO 0006/185 (10.02.2000 Gazette 2000/06)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 30.07.1998 US 126525
30.07.1998 US 94693 P

(71) Applicant: SOCIETE DE CONSEILS DE RECHERCHESET D'APPLICATIONS SCIENTIFIQUES S.A.S.
75016 Paris (FR)

(72) Inventor:
  • MOREAU, Jacques-Pierre
    Upton, MA 01568 (US)

(74) Representative: Lunt, Mark George Francis 
Harrison Goddard Foote,Fountain Precinct,Leopold Street
Sheffield S1 2QD
Sheffield S1 2QD (GB)

   


(54) METHODS OF USING LANREOTIDE, A SOMATOSTATIN ANALOGUE